Clinical Trial Update: Double Protease Inhibitor to Darunavir Switch Study [Phase 4]

View source ↗

Summary

Phase 4 trial assessing switching from double protease inhibitor therapy to darunavir in HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Darunavir (Prezista) (darunavir)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV Infections | Phase 4 | Status: COMPLETED